Two Ebola Vaccines Spur Lasting Immune Response

WEDNESDAY, Oct. 11, 2017 -- Two experimental vaccines against the deadly Ebola virus are able to trigger an immune response that lasts for at least a year, a new clinical trial has found. Experts said the results give more support to one of the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news